vs
Pediatrix Medical Group, Inc.（MD）与MSC INDUSTRIAL DIRECT CO INC（MSM）财务数据对比。点击上方公司名可切换其他公司
MSC INDUSTRIAL DIRECT CO INC的季度营收约是Pediatrix Medical Group, Inc.的2.0倍（$965.7M vs $493.8M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs 5.4%，领先1.5%），MSC INDUSTRIAL DIRECT CO INC同比增速更快（4.0% vs -1.7%），过去两年Pediatrix Medical Group, Inc.的营收复合增速更高（-0.1% vs -3.4%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
MSC工业直销公司（MSC）通过旗下主要子公司MSC工业供应公司，是美国规模最大的工业设备分销商之一，可提供超过150万种金属加工及其他工业类产品，广泛服务于工业制造、维修运维等领域的客户需求。
MD vs MSM — 直观对比
营收规模更大
MSM
是对方的2.0倍
$493.8M
营收增速更快
MSM
高出5.7%
-1.7%
净利率更高
MD
高出1.5%
5.4%
两年增速更快
MD
近两年复合增速
-3.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $965.7M |
| 净利润 | $33.7M | $51.8M |
| 毛利率 | — | 40.7% |
| 营业利润率 | 9.9% | 7.9% |
| 净利率 | 6.8% | 5.4% |
| 营收同比 | -1.7% | 4.0% |
| 净利润同比 | 10.5% | 11.1% |
| 每股收益（稀释后） | $0.40 | $0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDMSM
| Q4 25 | $493.8M | $965.7M | ||
| Q3 25 | $492.9M | $978.2M | ||
| Q2 25 | $468.8M | $971.1M | ||
| Q1 25 | $458.4M | — | ||
| Q4 24 | $502.4M | $928.5M | ||
| Q3 24 | $511.2M | — | ||
| Q2 24 | $504.3M | $979.4M | ||
| Q1 24 | $495.1M | $935.3M |
净利润MDMSM
| Q4 25 | $33.7M | $51.8M | ||
| Q3 25 | $71.7M | $56.5M | ||
| Q2 25 | $39.3M | $56.8M | ||
| Q1 25 | $20.7M | — | ||
| Q4 24 | $30.5M | $46.6M | ||
| Q3 24 | $19.4M | — | ||
| Q2 24 | $-153.0M | $71.7M | ||
| Q1 24 | $4.0M | $61.8M |
毛利率MDMSM
| Q4 25 | — | 40.7% | ||
| Q3 25 | — | 40.4% | ||
| Q2 25 | — | 41.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 40.9% | ||
| Q1 24 | — | 41.5% |
营业利润率MDMSM
| Q4 25 | 9.9% | 7.9% | ||
| Q3 25 | 13.8% | 8.6% | ||
| Q2 25 | 12.8% | 8.5% | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 7.8% | 7.8% | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | -31.3% | 10.9% | ||
| Q1 24 | 3.2% | 9.7% |
净利率MDMSM
| Q4 25 | 6.8% | 5.4% | ||
| Q3 25 | 14.5% | 5.8% | ||
| Q2 25 | 8.4% | 5.9% | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 6.1% | 5.0% | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | -30.3% | 7.3% | ||
| Q1 24 | 0.8% | 6.6% |
每股收益（稀释后）MDMSM
| Q4 25 | $0.40 | $0.93 | ||
| Q3 25 | $0.84 | $1.02 | ||
| Q2 25 | $0.46 | $1.02 | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | $0.83 | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $-1.84 | $1.27 | ||
| Q1 24 | $0.05 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $40.3M |
| 总债务越低越好 | $570.5M | $214.1M |
| 股东权益账面价值 | $865.9M | $1.4B |
| 总资产 | $2.2B | $2.5B |
| 负债/权益比越低杠杆越低 | 0.66× | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资MDMSM
| Q4 25 | $375.2M | $40.3M | ||
| Q3 25 | $340.1M | $56.2M | ||
| Q2 25 | $224.7M | $71.7M | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | $57.3M | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | $25.9M | ||
| Q1 24 | $8.0M | $22.2M |
总债务MDMSM
| Q4 25 | $570.5M | $214.1M | ||
| Q3 25 | $577.2M | $168.8M | ||
| Q2 25 | $583.9M | $285.0M | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | $289.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $299.8M | ||
| Q1 24 | — | $294.5M |
股东权益MDMSM
| Q4 25 | $865.9M | $1.4B | ||
| Q3 25 | $890.7M | $1.4B | ||
| Q2 25 | $833.8M | $1.4B | ||
| Q1 25 | $789.2M | — | ||
| Q4 24 | $764.9M | $1.4B | ||
| Q3 24 | $732.5M | — | ||
| Q2 24 | $706.5M | $1.4B | ||
| Q1 24 | $856.2M | $1.4B |
总资产MDMSM
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $2.1B | $2.5B | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.2B | $2.5B | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.0B | $2.5B | ||
| Q1 24 | $2.2B | $2.5B |
负债/权益比MDMSM
| Q4 25 | 0.66× | 0.16× | ||
| Q3 25 | 0.65× | 0.12× | ||
| Q2 25 | 0.70× | 0.21× | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | 0.21× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $29.4M |
| 自由现金流经营现金流 - 资本支出 | — | $7.4M |
| 自由现金流率自由现金流/营收 | — | 0.8% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | 3.39× | 0.57× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDMSM
| Q4 25 | $114.1M | $29.4M | ||
| Q3 25 | $137.3M | — | ||
| Q2 25 | $137.2M | $151.6M | ||
| Q1 25 | $-117.5M | — | ||
| Q4 24 | $133.0M | $101.9M | ||
| Q3 24 | $91.8M | — | ||
| Q2 24 | $107.0M | $143.5M | ||
| Q1 24 | $-125.2M | $78.7M |
自由现金流MDMSM
| Q4 25 | — | $7.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $100.7M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $81.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $114.0M | ||
| Q1 24 | — | $53.4M |
自由现金流率MDMSM
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.4% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 8.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 11.6% | ||
| Q1 24 | — | 5.7% |
资本支出强度MDMSM
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 2.7% |
现金转化率MDMSM
| Q4 25 | 3.39× | 0.57× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | 2.67× | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 2.18× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 2.00× | ||
| Q1 24 | -31.03× | 1.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MSM
暂无分部数据
